| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 120.28B | 118.15B | 117.07B | 103.86B | 97.78B | 90.92B |
| Gross Profit | 21.72B | 20.59B | 20.23B | 16.79B | 12.73B | 6.38B |
| EBITDA | 11.72B | 12.97B | 12.77B | 10.20B | 7.62B | 1.13B |
| Net Income | 3.44B | 5.08B | 3.26B | 1.15B | 1.84B | -8.52B |
Balance Sheet | ||||||
| Total Assets | 165.24B | 165.44B | 159.19B | 150.57B | 146.91B | 159.06B |
| Cash, Cash Equivalents and Short-Term Investments | 3.15B | 4.27B | 3.37B | 2.83B | 3.60B | 2.81B |
| Total Debt | 56.87B | 61.88B | 56.34B | 59.14B | 57.68B | 63.79B |
| Total Liabilities | 100.22B | 102.04B | 99.92B | 97.69B | 93.74B | 103.90B |
| Stockholders Equity | 59.27B | 57.73B | 54.17B | 48.24B | 48.74B | 50.81B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -5.04B | 3.56B | -3.04B | 5.27B | -6.17B |
| Operating Cash Flow | 0.00 | 8.43B | 9.67B | 4.89B | 11.75B | 40.00M |
| Investing Cash Flow | 0.00 | -12.74B | -5.79B | -6.52B | -4.24B | -6.26B |
| Financing Cash Flow | 0.00 | 5.41B | -3.33B | 843.00M | -6.73B | 6.64B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥253.05B | 4.69 | 12.70% | 1.68% | 8.29% | 24.94% | |
72 Outperform | ¥7.71B | 7.03 | ― | 0.47% | 3.15% | 4.75% | |
65 Neutral | ¥19.01B | -109.80 | ― | 1.33% | 1.70% | 1841.47% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | ¥44.88B | 14.50 | ― | 2.17% | 4.37% | 54.12% | |
59 Neutral | ¥44.12B | 9.60 | ― | 2.58% | 2.36% | -40.95% | |
59 Neutral | ¥19.85B | 9.88 | ― | 0.81% | 1.24% | 19.78% |